Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXL CDOS vs Ciprodex in Acute Otitis Externa
NCT02216071Phase 3Completed
- Sponsor
- Exela Pharma Sciences
- Start
- Jul 2014
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of ciprofloxacin + dexamethasone in acute otitis externa (AOE) (2 arms), sponsored by Exela Pharma Sciences. Primary endpoint: Proportion of subjects with a clinical AOE score of 0 at Day 15. Started Jul 2014; status: completed.
02
Drugs
ciprofloxacin + dexamethasone
03
Conditions
acute otitis externa (AOE)
Beyond the preview
Go deeper on NCT02216071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216071.